Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124287342 | 12428734 | 2 | F | 20160520 | 20160720 | 20160602 | 20160729 | EXP | US-NOVOPROD-494059 | NOVO NORDISK | 26.00 | YR | A | F | Y | 88.44000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124287342 | 12428734 | 1 | PS | NOVOLOG | INSULIN ASPART | 1 | Subcutaneous | SLIDING SCALE QID | EZF0185 | 20986 | SOLUTION FOR INJECTION | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124287342 | 12428734 | 1 | Type 1 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124287342 | 12428734 | OT |
| 124287342 | 12428734 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124287342 | 12428734 | Balance disorder | |
| 124287342 | 12428734 | Blindness | |
| 124287342 | 12428734 | Blood glucose increased | |
| 124287342 | 12428734 | Deafness | |
| 124287342 | 12428734 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124287342 | 12428734 | 1 | 200706 | 0 |